Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2023....
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that Shahe Bagerdjian has been...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2022. The following...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and nine months ended September 30, ...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three- and six-month periods ended June...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2022....
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2021. Total revenues ...
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") is pleased to announce it has completed an asset purchase agreement...
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") has announced the approval of a modification to the term of its Series ...
International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") is pleased to announce updated information regarding research it has...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three months ended June 30, 2021. Revenue ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has acquired the remaining 75% of all outstanding units of...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2021....
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2020. Total revenues ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its subsidiary RadQual has signed an Agreement with LEA for distribution of their ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce the following developments. International Isotopes recently signed a ...
International Isotopes Inc. (OTCQB: INIS) (the "Company"), due to recent unusual trading volume, and share price volatility in its common stock, is...
International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announces its financial results for the three and six months ended June 30, 2020. ...
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces the highlights of the recent Board of Directors meeting and voting results on...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has hired Dr. James R. Miles, PharmD., ANP as its new...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce its financial results for the three months ended March 31, 2020....
International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2019. The Company...
International Isotopes Inc. (OTCQB: INIS) (the "Company") is pleased to announce it has received approval from the U.S. Food and Drug Administration...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.